Shopping Cart
Remove All
Your shopping cart is currently empty
Matuzumab (EMD 72000) is a humanized monoclonal antibody targeting EGFR with potential anticancer activity that blocks EGFR activation and downstream signaling for the study of non-small cell lung cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $228 | In Stock | In Stock | |
| 5 mg | $573 | - | In Stock | |
| 10 mg | $819 | - | In Stock | |
| 25 mg | $1,250 | - | In Stock | |
| 50 mg | $1,690 | - | In Stock |
| Description | Matuzumab (EMD 72000) is a humanized monoclonal antibody targeting EGFR with potential anticancer activity that blocks EGFR activation and downstream signaling for the study of non-small cell lung cancer. |
| Synonyms | EMD-72000, EMD72000, EMD 72000 |
| Reactivity | Human |
| Verified Activity | Immobilized Human ERBB1 / EGFR / HER1, His Tag at 2 μg/mL (30 μL/well) can bind Anti-ERBB1 / EGFR / HER1 Reference Antibody (matuzumab), with the EC50 is 0.04808 μg/mL. |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Molecular Weight | 145.9 kDa |
| Cas No. | 339186-68-4 |
| Relative Density. | no data available |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.